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One of the many challenges hindering the global response to the human immunodeﬁciency virus (HIV)/acquired
immunodeﬁciency syndrome (AIDS) epidemic is the difﬁculty of collecting reliable information about the populations
most at risk for the disease. Thus, the authors empirically assessed a promising new method for estimating the sizes
of most at-risk populations: the network scale-up method. Using 4 different data sources, 2 of which were from other
researchers, the authors produced 5 estimates of the number of heavy drug users in Curitiba, Brazil. The authors
found that the network scale-up and generalized network scale-up estimators produced estimates 5–10 times
higher than estimates made using standard methods (the multiplier method and the direct estimation method using
data from 2004 and 2010). Given that equally plausible methods produced such a widerange of results, the authors
recommend that additional studies be undertaken to compare estimates based on the scale-up method with those
made using other methods. If scale-up-based methods routinely produce higher estimates, this would suggest that
scale-up-based methods are inappropriate for populations most at risk of HIV/AIDS or that standard methods may
tend to underestimate the sizes of these populations.
acquired immunodeﬁciency syndrome; epidemiologic methods; HIV; network sampling; population size estimation;
social networks
Abbreviations: AIDS, acquired immunodeﬁciency syndrome; CAPS, Centro de Atenc xa ˜o Psicossocial; CI, conﬁdence interval; HIV,
human immunodeﬁciency virus; PCAP, Pesquisa de Conhecimento, Atitudes e Pra ´ticas Relacionadas ao HIV/AIDS na Populac xa ˜o
Brasileira de 15 a 54 Anos de Idade.
One of the challenges hindering the global response to
the human immunodeﬁciency virus (HIV)/acquired immu-
nodeﬁciency syndrome (AIDS) epidemic is the difﬁculty of
collecting reliable information about the populations most at
risk. This information is difﬁcult to collect because in many
countries, HIV/AIDS risk is concentrated in populations—
illicit drug users, female sex workers, and men who have sex
with men—that are difﬁcult to sample using standard sta-
tistical methods. The resulting lack of accurate, timely, and
comprehensive information makes evidence-based approaches
to targeting prevention programs and monitoring effective-
ness difﬁcult. Consider one of the most basic questions one
might ask: How large are the mostat-riskpopulations around
the world, and how are the sizes of these populations changing
over time? Despite enormous amounts of work carried out
using a variety of methods, much uncertainty remains (1).
For example, in many countries where injecting drug use has
been reported, no reliable estimate of the number of drug
injectors exists (2). Even the estimates that do exist are difﬁcult
to interpret because of methodological differences between
countries and over time within countries (3). Similar uncer-
tainties exist about the numbers of female sex workers and
men who have sex with men (4–7).
One promising approach for estimating the sizes of groups
most at risk of HIVinfection is the network scale-up method,
a technique that is new to epidemiology but has established
roots in anthropology and social network analysis (8–10).
The method uses information about the personal networks of
1190 Am J Epidemiol. 2011;174(10):1190–1196a random sample of the general population to make size es-
timates, and it has a number of attractive features for global
public health (10): 1) it can easily be standardized across
countries and time because it requires a random sample of
thegeneral population,perhapsthe mostwidelyusedsampling
design in the world; 2) it can produce estimates of the sizes of
many target populations in the same data collection, whereas
many alternative methods require distinct data collections for
each population ofinterest; 3) it can be partially self-validating
because it can easily be applied to populations of known size;
4) depending on the sampling frame, it can produce estimates
at either the city level or the national level, whereas many
alternativemethodscanonlybe appliedon 1geographicscale;
5) it does not require respondents to report that they are mem-
bers of a stigmatized group; and 6) it is relatively inexpensive
and does not require extensive administrative records, which
makes it feasible to use at frequent time intervals, even in
middle- and low-income countries.
Despite these appealing characteristics, the applicability of
the network scale-up method for global HIV/AIDS research
remains unclear. Therefore, we empirically assessed the util-
ity of the network scale-up method and the newergeneralized
network scale-up method in this context. Ideally, we would
assess the accuracy of these scale-up-based estimates, but
that is difﬁcult, because for most at-risk populations we lack
a ‘‘gold standard’’size estimate. Therefore, we conducted
our study in a most-at-risk population whose size had been
estimated previously: heavy drug users in Curitiba, Brazil.
Curitiba isan optimallocation for this study because Brazil is
a middle-income country with a concentrated HIV/AIDS epi-
demic and a strong governmental response to HIV/AIDS (11),
and Curitiba, a city of 1.8 million people in southern Brazil,
was the site of a 2004 Brazilian Ministry of Health study that
yielded an estimate of the number of heavy drug users in the
city. In addition to this previous estimate, we also estimated
the number of heavy drug users in Curitiba using 2 standard
methods: the multiplier method and the direct estimation
method (12). These 3 estimates provided a background that
we could use to assess the scale-up and generalized scale-up
estimates. Thus, while most studies of hard-to-count popu-
lations produce only a single estimate, our study produced
5 different estimates based on 4 distinct data sources, 2 of
which were from other researchers.
MATERIALS AND METHODS
The target population in our study was heavy drug users,
deﬁned as people who had used illegal drugs other than
marijuana morethan25timesinthepast6months.Thistarget
population is appropriate to the current state of the HIV/AIDS
epidemicinBrazil, whereinjectingdrugsisunusual and heavy
drug users show high rates of HIVinfection relative to the
general population (11).
Data sources
Our study used 4 data sources to produce 5 estimates, as
summarized in Figure 1. One source of data, which were col-
lected by our research team, was a face-to-face survey admin-
istered to a household-based random sample of 500 adult
(i.e., aged  18 years) residents of Curitiba in 2010. The
second source of data, also collected by our research team,
was a respondent-driven sample (13–17) of 303 heavy drug
users in Curitiba selected in 2009 (18, 19). The third source
of data, collected by an independent group of researchers,
was the 2004 Brazilian Ministry of Health PCAP survey
(PesquisadeConhecimento,AtitudesePra ´ticasRelacionadas
ao HIV/AIDS na Populac xa ˜o Brasileira), which measured the
knowledge, attitudes, and practices of the Brazilian popula-
tion with respect to HIV/AIDS (20). The ﬁnal data source we
used was administrative records from the Centro de Atenc xa ˜o
Psicossocial (CAPS) drug treatment program in Curitiba. For
more onthe deﬁnitional consistencyacrossthesedata sources,
see the Web Appendix (http://aje.oxfordjournals.org/).
Network scale-up method and generalized network
scale-up method
The network scale-up method estimates population sizes
using information about the personal networks of survey re-
spondents under the assumption that personal networks are,
on average, representative of the general population. For
example, if a respondent reports knowing 2 illicit drug users
and knows 200 people overall, we can estimate that 2/200, or
1%, of the population are illicit drug users. This estimate can
be improved by averaging data over many respondents (9).
The data needed for the network scale-up method come from
interviews with a random sample of the general population.
In addition to basic demographic questions, respondents are
asked how many people they ‘‘know’’ in the target population.
Followingstandard practice (10),in our study‘‘know’’ was
deﬁned as follows: ‘‘You know them and they know you, and
you have been in contact with them in the last 2 years.’’
Respondents arethenaskeda batteryof questionstoestimate
the number of people they know (i.e., the size of their personal
network).
Survey of
general population (2004)
Administrative records from
drug treatment program (2009) Multiplier (2009)
Scale-up (2010)
Generalized scale-up
(2009/2010)
Direct (2004)
Survey of
general population (2010)
Survey of
heavy drug users (2009)
Direct (2010)
Estimate Data source
Heavy Drug Users, Curitiba, Brazil
Figure 1. Design of a study for estimating the number of heavy drug
users in Curitiba, Brazil. Four distinct data sources, 2 of which were
from other researchers, were used to produce 5 estimates.
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target population as
ˆ p ¼
P n
i¼1
yi
P n
i¼1
ˆ di
; ð1Þ
where yi is the number of people known in the target popu-
lation and ˆ di is the estimated personal network size (9). Thus,
onecanviewthenetworkscale-upestimatorasageneralization
of the familiar sample proportion, which is the number of
sample membersin thetargetpopulation divided by thesample
size. The network scale-up estimator is instead the total num-
ber of target population members known by the respondents
divided by the total number of people known by respondents.
In this context, the 2 methods most appropriate for estimat-
ing the total number of people known by each respondent are
the known population method and the summation method (10).
Because it was not clear a priori which method would pro-
duce more accurate estimates in this context, we used both
methods in our study. Tests (described in the Web Appendix)
showed that in this study, the data from the known population
method were preferable, and therefore those data will be
presented throughout.
The network scale-up method makes some strong implicit
assumptions, and for that reason, we also collected the data
needed for thegeneralized scale-up estimator. These data come
from a sample of the target population—in this case, heavy
drug users—and are then combined with the data from the
general population to produce 2 correction factors: one for the
lack of information ﬂow and one for the differential network
size between the target population and the general popula-
tion. These correction factors and the procedures needed to
estimate them are described in detail in the Web Appendix.
Direct estimation and multiplier method
For comparison with the scale-up and generalized scale-up
estimates,weestimatedthe numberofheavydrugusers using
2 common methods: direct estimation and the multiplier
method (12). Direct estimation involves asking a sample of
the general population whether they are heavy drug users.
The multiplier method estimates the size of the target popu-
lation based on 2 pieces of information: 1) the number of
people in the target population with some speciﬁc character-
istic (e.g., the number of people in a speciﬁc drug treatment
program) and 2) the estimated prevalence of that characteristic
in the target population. This information is combined as
follows:
ˆ NT ¼
Nc
ˆ pc
; ð2Þ
where Nc is the number of people in the target population
with that characteristic and ˆ pc is the estimated proportion of
the target population with that characteristic. In our study,
Nc was the number ofheavy drug users ina speciﬁc treatment
program and ˆ pc was the estimated proportion of heavy drug
users who were in that program.
RESULTS
The results from all 5 estimates are presented in Figure 2
and described in detail below.
Commonly used methods: direct estimation and
multiplier method
Wehad 2differentsourcesofdatafordirectestimates.First,
in 2004, the Brazilian Ministry of Health conducted the
PCAP survey, which included approximately 1,000 people
inCuritiba,andaskeddirectlyabouttheuseofpowdercocaine
andinjectedcocaine.Fromthesedata,weestimatedaprev-
alence of heavy drug use within the Curitiba population
of 0.3% (95% conﬁdence interval (CI): 0, 0.7) (see Web
Appendix). In our 2010 survey of the general population, we
produced a direct estimate of the prevalence of heavy drug
use in the general population of 0.6% (95% CI: 0, 1.6) (see
Web Appendix).
To produce our multiplier estimate, we learned from admin-
istrative records that 423 heavy drug users were enrolled in
the CAPS drug treatment program in August 2009. We also
estimated fromour sample of heavydrug users (data collected
in 2009) that 3.7% of heavy drug users were in the CAPS
program (95% CI: 0.7, 7.8). Therefore,our multiplier estimate
for the number of heavy drug users was 423/0.037 (see
equation 2) or 11,459 people, which corresponds to 0.6%
of the population (95% CI: 0.3, 3.2) (see Web Appendix).
Thus, we see that these 2 commonly used methods produced
similar estimates.
While this is somewhat reassuring, there are reasons to
suspect that direct estimation and the multiplier method both
produce underestimates. Direct estimates of the prevalence
of drug use can be plagued by nonsampling error (21) and
are suspected to be underestimates for 2 reasons (22). First,
several studies that compared self-reported drug-use data with
drug-testing data found that respondents underreport their
drug use, in some cases substantially (23–25). Second, heavy
drug users appear to be more difﬁcult to reach in standard
household surveys, which creates differential nonresponse
(26, 27). For these reasons, some researchers place more
conﬁdence in ‘‘indirect’’ estimation methods, of which the
Estimated Prevalence in the General Population, %
02468
Direct (2004)
Direct (2010)
Multiplier
Scale-up
Generalized Scale-up
Figure 2. Five estimates of the prevalence of heavy drug use in
Curitiba, Brazil, 2004 and 2009–2010. Scale-up and generalized
scale-upestimatesweresubstantially higherthanthoseobtainedfrom
standard methods (direct estimation and the multiplier method). Esti-
mates of the number of heavy drug users in Curitiba ranged from
4,700 to 114,000. Bars, estimated 95% conﬁdence interval.
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based estimates are only as good as the data used to create
them. Multiplier methods will tend to produce underestimates
if the members of the target population that appear in admin-
istrative data are overrepresented in the sample of the target
population—akin to problems with capture-recapture when
capture probabilities are correlated (28). For example, we sus-
pectthat participants in the CAPS treatment programs were
overrepresented in our sample of heavy drug users, because
middle- and upper-class heavy drug users were less likely to
participate in CAPS (because it is a free government pro-
gram) and less likely to participate in our respondent-driven
sampling study (because the ﬁnancial incentives for partic-
ipation were less attractive for middle- and upper-class drug
users). If this pattern did occur, these middle- and upper-class
heavy drug users would be essentially invisible to the mul-
tiplier method.
Given these sources of concern about the commonly used
methods, we now turn to another indirect method, the network
scale-up method. By using information embedded in respon-
dents’ personal networks, this method allows researchers to
make indirectestimates that include peoplewhose drug use is
not recorded in any administrative records.
Network scale-up method and generalized network
scale-up method
Respondents in our general population survey reported
knowing a total of 3,075 heavy drug users in Curitiba. Fur-
ther, we estimated that our respondents knew a total of
92,003 people in Curitiba. Therefore, the scale-up estimator
produced an estimated proportion of heavy drug users of
3.3% (95% CI: 2.7, 4.1) (see Web Appendix).
The generalized network scale-up estimator relaxes
2 assumptions of the network scale-up estimator. It relaxes
both the assumption that people are aware of everything about
the people they are connected to and the assumption that the
target population has the same average personal network size
as the population as a whole. As we describe in more detail in
the Web Appendix, we estimated the 2 necessary correction
factors using data from our sample of heavy drug users and
produced a generalized scale-up estimate of the proportion
of heavy drug users of 6.3% (95% CI: 4.5, 8.0).
DISCUSSION
The estimates derived from the network scale-up method
and the generalized network scale-up method were substan-
tially higher than those from standard methods (Figure 2).
However, our scale-up-based estimates of drug use are roughly
comparable to those of previous national-level studies in
Brazil and international benchmarks (see Web Appendix).
Further, because the scale-up method allows researchers to
estimate the sizes of multiple target populations, our study
also estimated the number offemale sex workers and men who
have sex with men in Curitiba. We ﬁnd that these estimates too
are roughly comparable with those of other studies from Brazil
and international meta-analysis (see Web Appendix). We
caution, however, that all of these comparisons have a large
degree of uncertainty because of differences between the
studies and ambiguities in the deﬁnitions of the target
populations.
Although these consistency checks are somewhat encour-
aging, they cannot assess the accuracy of the estimates.
Therefore, as a ﬁnal check, we note that we also asked re-
spondents how many people they knew in 20 populations of
known size—for example, women who have given birth in
thelast 12months,studentsenrolled inpublic universities,and
employees of the city of Curitiba (see the Web Appendix for
a list of the 20 populations). Therefore, to assess the network
scale-up method, we estimated the size of each of these
populations using our sample and the scale-up estimator(equa-
tion 1). Figure 3 reveals that for most of the 20 populations,
the size estimates, while not perfect, were quite reasonable.
However, Figure 3 also reveals a tendency to overestimate
the sizes of smaller populations and underestimate the sizes
of larger populations, a ﬁnding that is consistent with pre-
vious studies (29, 30). The fact that this exact estimator
in this exact sample can produce reasonable estimates for
quantities we can check gives us some additional conﬁdence
about the estimates for quantities we cannot check.
Estimates made in populations of known size also reveal
that the estimated 95% conﬁdence intervals, which in this
case were generated using a bootstrap procedure accounting
for our 2-stage cluster sample design (see Web Appendix),
are not wideenough: Thepurported 95% conﬁdence intervals
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Figure 3. Validation of network scale-up estimates for 20 popula-
tions of known size in Curitiba, Brazil, 2010. (A list of the 20 popula-
tions is presented in the Web Appendix.) The estimates were
generally similar to the true values, but there was a tendency to over-
estimate the sizes of small groups and underestimate the sizes of
large groups, a pattern that has been observed in other scale-up
studies as well (29, 30). The purported 95% conﬁdence intervals also
had poor coverage properties. The 1 outlier in the plot represents the
group ‘‘middle school students in a public school.’’ Bars, estimated
95% conﬁdence interval.
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what discouraging, it is also exciting that we can actually
detect this problem (we suspect that the conﬁdence intervals
for many comparable methods are also too small, but this
problem is largely invisible). Therefore, we suggest that in
futureresearch, investigators also address nonsamplingsources
of uncertainty, such as those introduced by response bias or
recall errors.
Because the scale-up-based estimates were so much higher
than those obtained with existing methods, we considered
many possible sources of error that might have inﬂated our
estimates (of course, as explainedabove, there are reasons to
suspect that the standard estimates are too low). One possible
source of overestimation could be the order of the questions
in our survey: Heavy drug users were the ﬁrst group asked
about, and this might have led to inﬂated responses. How-
ever, no effects of question order were found in a previous
telephone-based network scale-up survey in Italy (31). Un-
fortunately, we were unable to randomize the order of our
questions for logistical reasons, so we cannot address this
possibility directly with our data. We recommend that future
researchers randomize the order of the questions if possible.
An alternative explanation for these apparently high esti-
mates is that some interviewers may not have followed the
study protocol. More speciﬁcally, rather than asking, ‘‘How
many people do you know who live in Curitiba and have
used illegal drugs other than marijuana more than 25 times
in the last 6 months (i.e., average of once a week)?,’’ some
interviewers could have shortened the question to, ‘‘How many
people do you know that use drugs?’’. This shorter question
could have produced much higher responses that would have
ledtoa higherestimatedpopulationsize.Althoughwe hadno
reason to believe that this occurred, we assessed the robust-
ness of our estimates to data from a single interviewer by
systematically dropping the data collected by each of our
9 interviewers. This analysis showed that no particular inter-
viewer had a large effect on the estimate (see Web Appendix).
Anadditionalsourceofupwardbiasis‘‘druguseinﬂation,’’
that is, respondents’ including in their answers people who
used drugs butdid not use them heavily enough to match our
study criteria. For example, if a respondent knew someone
who drank alcohol every day, the respondent might have
included this person in his or her count even though that
person did not match our study criteria. In fact, a previous
survey in Brazil suggests that this ‘‘drug use inﬂation’’ might
occur: Approximately 20% of respondents reported that some-
onewho drank alcohol twice per week was at severe risk due
to substance misuse,and almost half of respondents reported
that someone who had used marijuana once or twice in his/her
lifetimewas at severe risk due to substance misuse (32). The
differences between this previous survey and our study pre-
vent any ﬁrm conclusions, but these previous results at least
suggest that ‘‘drug use inﬂation’’ might have occurred in our
survey; this will have to be a topic for future research.
A further possible source of error in the scale-up estimates
is problems with the sampling frame. If residents of Curitiba
differ in their propensity to know heavy drug users (30) and
if the sampling frame was less likely to include persons with
higher propensities to know heavy drug users (possibly the
homeless), then our scale-up estimates could be too low.
Conversely, if the sampling frame systematically excluded
persons who have a lower propensity to know heavy drug
users (possibly those living in gated communities), then our
scale-up estimates could be too high. The relative magnitude
of these problems is difﬁcult to assess empirically, and the
sensitivity of the network scale-up method to sampling frame
problems is an important question for future research.
Prior to data collection, we expected that the scale-up-based
estimates might be higher than those madewith other methods,
b u tw ed i dn o te x p e c tt h e mt ob es om u c hh i g h e r .A sw a s
described above, we suspect that direct estimates and mul-
tiplier estimates will be too low in our setting (and possibly
in many other settings). However, the generalized scale-up
method, which we believe is more statistically appropriate
than the scale-up method, produced estimates that were much
higher than expected. Since these equally plausible methods
produced such different results, we recommend that in addi-
tional studies investigators compare scale-up-based estimates
with those made using other methods; conducting additional
scale-up studies without having results from other methods
for comparison will not address this challenge.
Fortunately, our research design (Figure 1) can be easily
replicated in other settings. In many cities, there are routine
behavioral surveillance surveys of populations most at risk
ofHIV/AIDS,andthere are routine studies involvingsamples
taken from the general population. In this case, by adding
a few additional questions to each data collection effort, in-
vestigatorscanreplicateourstudyatvirtuallynocost.Further,
our research design could be enriched with additional sources
of data and additional estimation methods. For example, dis-
tributinga unique object to members of the target population
before sampling from the target population could produce
a capture-recapture estimate (33), although some features
of the target population sampling—in this case, respondent-
driven sampling—maycomplicate thisapproach(17,33–36).
Other sources of administrative data, such as HIV registry
data, could be used to produce additional multiplier method
estimates (37), but the accuracy of these estimates will de-
pend on the availability of administrative data and possible
statistical dependencies between data sources. An additional
variation in design would be to use alternative sampling
methods to reach the target population (e.g., time-location
sampling).
If additional studies are undertaken and it is found that
scale-up-based methods routinely produce higher estimates
than existing methods, scale-up-based methods may not be
appropriate for estimating the sizes of populations most
at risk of HIV/AIDS. Alternatively, it may be the case that
existing methods have been systematically underestimating
the sizes of these populations. At this point, we do not
have enough evidence to deﬁnitively address this important
possibility.
Procedures used for prevention, management, and treat-
ment of HIV/AIDS in Brazil are recognized worldwide as
a benchmark for other middle-income countries. However,
Brazil isan emergent country with a growing population and
competing health priorities (38). Human and material re-
sources in Brazil and in other countries should be mobilized
in the most equitable way possible, on the basis of sound
empirical evidence. Therefore, estimates of the sizes of the
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as possible. The present study shows that scale-up-based
estimators are a promising alternative to commonly used
approaches, but more research is needed. General, standardiz-
able, and cost-effective approaches to collecting data about
the most-at-risk groups are necessary for the formulation
of evidence-based policies designed to curb the spread of
HIV/AIDS.
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